Skip to content

Digital Breast Tomosynthesis in Younger Symptomatic Women

Digital Breast Tomosynthesis (DBT): Sensitivity for Cancer and Accuracy in Assessing Extent of Malignant Disease in Symptomatic Women Below 60 With Clinical or Ultrasound Signs Compatible With Malignancy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01241981
Enrollment
446
Registered
2010-11-16
Start date
2011-03-31
Completion date
2018-02-28
Last updated
2018-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast, Cancer, Digital, Mammography, Tomosynthesis

Brief summary

This study will examine a new imaging technique called digital breast tomosynthesis (DBT) compared to standard mammography in women under 60 presenting with signs of breast cancer. The reason that we need to do this study is that standard mammography fails to detect the cancer in approximately 20% of these women because younger women have denser breast tissue. We hope that DBT will be more sensitive in detecting breast cancer than standard mammography.

Interventions

None listed

Sponsors

University of Dundee
CollaboratorOTHER
NHS Tayside
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 59 Years
Healthy volunteers
No

Inclusion criteria

* Female * Under 60 years old * Clinical or ultrasound suspicion of breast cancer

Exclusion criteria

* Unable to give informed consent * Male * Obvious advanced breast cancer * Obvious medical problems meaning surgery would not be an option

Design outcomes

Primary

MeasureTime frame
Sensitivity of DBT for breast cancer, compared with FFDMTwo years

Secondary

MeasureTime frame
Accuracy of DBT compared with FFDM in assessment of tumour extentTwo years
Relative accuracy of DBT and FFDM by breast densityTwo years

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026